News

Are mRNA Vaccines Safe — and Should You Still Get a COVID Shot? Doctors on the Pros and Cons
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
HHS phases out mRNA vaccine trials for COVID-19, bird flu
HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...
US rejection of mRNA vaccines shows ‘lack of respect for science,’ says Nobel laureate
The Nobel Prize winning scientist behind mRNA vaccine technology has attacked the US health secretary’s plan to effectively ...
USA Today4y
COVID vaccine from Moderna, Pfizer, AstraZeneca: What's the difference
In the Moderna trial, 90 of the first 95 participants to develop COVID-19 had received the placebo and only five the active vaccine, so it was 94.5% effective. Results from another 56 ...
CBS News4y
Moderna says its COVID-19 vaccine highly effective in late trial
Investors were seemingly buoyed by Moderna's vaccine trial results, with U.S. stock futures on Monday pointing to a strong opening. Dow futures were up 476 points, or 1.6%, before the start of ...
Los Angeles Times4y
Moderna vaccine protects against COVID for months, company says - Los ...
COVID vaccine maker Pfizer Inc. lost 0.6%, while its partner BioNTech, shed 3.8%. Moderna’s latest efficacy data hasn’t been published in a medical journal and further details weren’t released.
The New York Times4y
Moderna's Covid-19 Vaccine, Explained - The New York Times
Moderna’s Covid Vaccine: What You Need to Know Denise Grady Published Nov. 16, 2020 Updated Nov. 30, 2020 Share full article ...
NPR4y
Moderna's COVID-19 Vaccine Candidate Gets More Good News
Coronavirus Updates What It Was Like To Participate In The Clinical Trial For Moderna's COVID-19 Vaccine Pfizer applied for emergency use authorization on Nov. 9 for its COVID-19 vaccine.
MedPage Today16h
Did FDA Pick the Wrong COVID Vaccine Strain Last Season? | MedPage Today
In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...